Detection of Circulating Tumour Cells in Patients with Breast or Ovarian Cancer by Molecular Cytogenetics

Overview

Journal Br J Cancer

Specialty Oncology

Date 1999 Dec 10

PMID 10584878

Citations 10

Authors

H Engel

C Kleespies

J Friedrich

M Breidenbach

A Kallenborn

T Schondorf

H Kolhagen

P Mallmann

Affiliations

Soon will be listed here.

Abstract

Detection of micrometastases in patients with solid tumours may aid the establishment of prognosis and development of new therapeutic approaches. This study was designed to investigate the presence and frequency of tumour cells in the peripheral blood (PB) of patients with breast or ovarian cancer by using a combination of magnetic activated cell sorting (MACS) and fluorescence in situ hybridization (FISH). Separated tumour cell and PB-samples from 48 patients (35 breast cancers, 12 ovarian tumours, one uterine sarcoma) were analysed for the presence of numerical aberrations of chromosomes 7, 12, 17 and 17 q11.2-q12. Twenty-five patients had primary disease and 23 had relapsed. The technique allows the detection of one tumour cell in 106 normal cells. Circulating tumour cells were detected in 35/48 cases (17 patients had relapsed and 13 primary carcinoma with lymph node or solid metastases) by the expression of anti-cytokeratin and the presence of numerical chromosomal abnormalities. PB-tumour cells of patients with a primary carcinoma and without solid metastases had a significantly lower percentage of chromosomal aberrations, especially for chromosome 12 (P = 0.035; P = 0.038) compared to those with relapsed disease and solid metastases. Detection and quantification of minimal residual disease may monitor the response to cytotoxic or hormonal therapy and may identify women at risk of relapse.

Citing Articles

Detection of Circulating and Disseminated Tumor Cells and Their Prognostic Value under the Influence of Neoadjuvant Therapy in Esophageal Cancer Patients.

Richter F, Roder C, Moller T, Egberts J, Becker T, Sebens S Cancers (Basel). 2022; 14(5).

PMID: 35267585 PMC: 8909540. DOI: 10.3390/cancers14051279.

IsoMAG-An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells.

Gribko A, Stiefel J, Liebetanz L, Nagel S, Kunzel J, Wandrey M Diagnostics (Basel). 2021; 11(11).

PMID: 34829387 PMC: 8623084. DOI: 10.3390/diagnostics11112040.

Comparative Analysis of Blood and Bone Marrow for the Detection of Circulating and Disseminated Tumor Cells and Their Prognostic and Predictive Value in Esophageal Cancer Patients.

Richter F, Baratay A, Roder C, Egberts J, Kalthoff H, Becker T J Clin Med. 2020; 9(8).

PMID: 32824841 PMC: 7464950. DOI: 10.3390/jcm9082674.

Nano Meets Micro-Translational Nanotechnology in Medicine: Nano-Based Applications for Early Tumor Detection and Therapy.

Siemer S, Wunsch D, Khamis A, Lu Q, Scherberich A, Filippi M Nanomaterials (Basel). 2020; 10(2).

PMID: 32098406 PMC: 7075286. DOI: 10.3390/nano10020383.

Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives.

Gribko A, Kunzel J, Wunsch D, Lu Q, Nagel S, Knauer S Int J Nanomedicine. 2019; 14:4187-4209.

PMID: 31289440 PMC: 6560927. DOI: 10.2147/IJN.S198319.

References

Visscher D, Wallis T, Ritchie C . Detection of chromosome aneuploidy in breast lesions with fluorescence in situ hybridization: comparison of whole nuclei to thin tissue sections and correlation with flow cytometric DNA analysis. Cytometry. 1995; 21(1):95-100. DOI: 10.1002/cyto.990210117. View

Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H . Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification. Am J Pathol. 1996; 148(2):649-56. PMC: 1861681. View

Cote R, Houchens D, Hitchcock C, Saad A, Nines R, Greenson J . Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabled monoclonal antibody CC49. Cancer. 1996; 77(4):613-20. DOI: 10.1002/(SICI)1097-0142(19960215)77:4<613::AID-CNCR5>3.0.CO;2-H. View

Hardingham J, Kotasek D, Sage R, EATON M, Pascoe V, Dobrovic A . Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease. Mol Med. 1995; 1(7):789-94. PMC: 2230007. View

Sauter G, Feichter G, Torhorst J, Moch H, Novotna H, Wagner U . Fluorescence in situ hybridization for detecting erbB-2 amplification in breast tumor fine needle aspiration biopsies. Acta Cytol. 1996; 40(2):164-73. DOI: 10.1159/000333683. View

Fernandez J, Goyanes V, Lopez-Fernandez C, Buno I, Gosalvez J . Quantification of C-ERB-B2 gene amplification in breast cancer cells using fluorescence in situ hybridization and digital image analysis. Cancer Genet Cytogenet. 1996; 86(1):18-21. DOI: 10.1016/0165-4608(95)00176-x. View

Ichikawa D, Hashimoto N, Hoshima M, Yamaguchi T, Sawai K, Nakamura Y . Analysis of numerical aberrations of specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer. Cancer. 1996; 77(10):2064-9. DOI: 10.1002/(SICI)1097-0142(19960515)77:10<2064::AID-CNCR15>3.0.CO;2-T. View

Muller P, Weckermann D, Riethmuller G, Schlimok G . Detection of genetic alterations in micrometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridization. Cancer Genet Cytogenet. 1996; 88(1):8-16. DOI: 10.1016/0165-4608(95)00189-1. View

Vredenburgh J, Silva O, Tyer C, DeSombre K, Cook M, Layfield L . A comparison of immunohistochemistry, two-color immunofluorescence, and flow cytometry with cell sorting for the detection of micrometastatic breast cancer in the bone marrow. J Hematother. 1996; 5(1):57-62. DOI: 10.1089/scd.1.1996.5.57. View

10.

Moscinski L, Trudeau W, Fields K, Elfenbein G . High-sensitivity detection of minimal residual breast carcinoma using the polymerase chain reaction and primers for cytokeratin 19. Diagn Mol Pathol. 1996; 5(3):173-80. DOI: 10.1097/00019606-199609000-00005. View

11.

Pantel K . Detection of minimal disease in patients with solid tumors. J Hematother. 1996; 5(4):359-67. DOI: 10.1089/scd.1.1996.5.359. View

12.

Luppi M, Morselli M, Bandieri E, Federico M, Marasca R, Barozzi P . Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene. Ann Oncol. 1996; 7(6):619-24. DOI: 10.1093/oxfordjournals.annonc.a010680. View

13.

Kruger W, Krzizanowski C, Holweg M, Stockschlader M, Kroger N, Jung R . Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncol. 1996; 122(11):679-86. DOI: 10.1007/BF01209032. View

14.

Diel I, Kaufmann M, Costa S, Holle R, von Minckwitz G, Solomayer E . Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst. 1996; 88(22):1652-8. DOI: 10.1093/jnci/88.22.1652. View

15.

Franklin W, Shpall E, Archer P, Johnston C, Hami L, Bitter M . Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support. Breast Cancer Res Treat. 1996; 41(1):1-13. DOI: 10.1007/BF01807031. View

16.

Mapara M, Korner I, Hildebrandt M, Bargou R, Krahl D, Reichardt P . Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain.... Blood. 1997; 89(1):337-44. View

17.

Hildebrandt M, Mapara M, Korner I, Bargou R, Moldenhauer G, Dorken B . Reverse transcriptase-polymerase chain reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: a sensitive method for monitoring purging efficiency. Exp Hematol. 1997; 25(1):57-65. View

18.

EATON M, Hardingham J, Kotasek D, Dobrovic A . Immunobead RT-PCR: a sensitive method for detection of circulating tumor cells. Biotechniques. 1997; 22(1):100-5. DOI: 10.2144/97221st01. View

19.

Kvalheim G . Detection of occult tumour cells in bone marrow and blood in breast cancer patients--methods and clinical significance. Acta Oncol. 1996; 35 Suppl 8:13-8. DOI: 10.3109/02841869609098516. View

20.

Naume B, Borgen E, Beiske K, Herstad T, Ravnas G, Renolen A . Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J Hematother. 1997; 6(2):103-14. DOI: 10.1089/scd.1.1997.6.103. View